Linperlisib
N-[5-[6-fluoro-8-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-2-morpholin-4-ylquinazolin-4-yl]-2-methoxy-3-pyridinyl]methanesulfonamide
Molecular Identity
Linperlisib
N-[5-[6-fluoro-8-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-2-morpholin-4-ylquinazolin-4-yl]-2-methoxy-3-pyridinyl]methanesulfonamide
PubChem CID: 91754520
2D Structure
Properties
C28H37FN6O5S
Molecular Formula
588.70
Molecular Weight
g/mol
588.2530
Exact Mass
Da
2.1
XLogP
Drug-like (Lipinski: < 5)
138
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
12
H-Bond Acceptors
958
Complexity
SMILES
Canonical SMILES
SMILES: CC(C)(C1CCN(CC1)CC2=C3C(=CC(=C2)F)C(=NC(=N3)N4CCOCC4)C5=CC(=C(N=C5)OC)NS(=O)(=O)C)OIsomeric SMILES
SMILES: CC(C)(C1CCN(CC1)CC2=C3C(=CC(=C2)F)C(=NC(=N3)N4CCOCC4)C5=CC(=C(N=C5)OC)NS(=O)(=O)C)OSynonyms(20)
linperlisibpi3Kdelta-IN-205HYK3CV9NPI3K.DELTA.-IN-2YY-20394LINPERLISIB [INN]UNII-05HYK3CV9NLINPERLISIB [WHO-DD]N-[5-[6-fluoro-8-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-2-morpholin-4-ylquinazolin-4-yl]-2-methoxypyridin-3-yl]methanesulfonamideYY20394compound 10 [US20160244432]N-(5-(6-fluoro-8-((4-(2-hydroxypropan-2-yl)piperidin-1-yl)methyl)-2-morpholinoquinazolin-4-yl)-2-methoxypyridin-3-yl)methanesulfonamidecompound 10 (US20160244432)N-(5-(6-fluoro-8-((4-(2-hydroxypropan-2-yl)piperidin-1-yl)methyl)-2-morpholin-4-ylquinazolin-4-yl)-2-methoxypyridin-3-yl)methanesulfonamideN-[5-(6-fluoro-8-{[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl}-2-morpholinoquinazolin-4-yl)-2-methoxypyridin-3-yl]methanesulfonamide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Linperlisib
Loading drug network...